Navigation Links
Medical Research Should Include More Women Participants and Examine the Role of Gender in Disease Incidence and Treatment
Date:5/12/2008

ROCHESTER, Minn., May 12 /PRNewswire-USNewswire/ -- Are the health needs of women adequately addressed by medical research as it is currently conducted? In the May issue of Mayo Clinic Proceedings, a team of Australian researchers and two cardiologists closely examine this question.

"The traditional model of medical research was limited by gender and racial blindness and assumed that results of research on white male participants could be easily extrapolated to female and minority populations," write Wendy Rogers, B.M.B.S., Ph.D., and Angela Ballantyne, Ph.D., from the School of Medicine at Flinders University in Adelaide, Australia. The researchers say a growing body of evidence shows important differences between men and women related to the incidence of certain diseases, how they respond to treatment and the long-term outcomes.

Drs. Rogers and Ballantyne reviewed 400 clinical studies that were conducted in Australia and the results were published in journals between Jan. 1, 2003 and May 31, 2006. The research provides data about issues that include: the number of men versus women participating in research on diseases affecting both genders; the number of studies classified as female-only research and male-only research; and the degree to which studies provided gender-specific data and analysis.

"Analysis such as this is essential for determining whether the national research agenda is addressing issues in both men's and women's health and the extent, if any, of inappropriate exclusions of either gender from potentially beneficial research," write Drs. Rogers and Ballantyne.

At first glance, the numbers collected by the Australian team do not suggest that women are under-represented in the research they examined. Of the 546,824 persons studied, 73 percent were female. However, the team points out that these numbers were largely due to the greater number and size of female-only studies. When Drs. Rogers and Ballantyne look
'/>"/>

SOURCE Mayo Clinic Proceedings
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. OmniSonics Medical Technologies Announces First Patient Enrolled in SONIC II REGISTRY
2. Medical research should include more women participants and examine the role of gender in disease
3. PLC Medical Systems to Demonstrate RenalGuard(TM) at EuroPCR 2008
4. Saint Barnabas Medical Center Converts to Masimo SET Technology - Establishing a Foundation for the Future of Pulse Oximetry
5. CRH Medical Corporation opens Center in Dallas
6. Medical Mutual of Ohio, CareWorks Build a Healthier Workforce
7. Minority medical students receive support to increase diversity in hematology
8. ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons
9. Culturesmart(TM) Breaks Language Barriers With Trained Medical Interpreters
10. Vail Valley Medical Center Board of Directors Announces Appointment of New President & CEO, John Cassin
11. Select Medical Corporation to Announce First Quarter Results on Thursday, May 15
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...ave discovered a vital link that reveals how the i...e on August 20 in the journal// Nature. The resear... allergic reactions, are involved in immune system...ete surprise. We were studying transplant toleranc...
... more than 50% of the patients with skin lesions c...not following the norms to// prescribe the right a...ection before prescribing antibiotics but most of ...ausing the infection will be susceptible to routin...
... of smoke alarms has suggested that high pitched s...The research conducted on 42// adults, between the...nal showed better results than a complete high fre... use. Data from the National Fire Protection Ass...
...ical used in plastic bottles and other household p... cancer.// Bisphenol A, “pseudo-oestrogen” which ..., when present in high concentrations. Though pre...ral changes in the oestrogen-like chemical after e...
Other Medicine News:Health News:Mast Cells Suppress Immune System 2Health News:Bisphenol A (BPA) linked with breast cancer 2Health News:Bisphenol A (BPA) linked with breast cancer 3
(Date:10/6/2008)...a from SONIC Trial Showed REMICADE Therapy is More...osal Healing Compared with Standard ...., Oct. 6 /- Data presented for the f... Crohn,s Disease Naive to,Immunomodulators and Bio...o,the approach to care of patients with moderate t...
(Date:10/6/2008)...re than 60 percent of moderate to severe patients ...ent achieved endoscopic remission at Week 10,in da...e American College,of Gastroenterology (ACG) Annua...wswire/ -- UCB today presented data from a,large, ...ment in Crohn,s,disease (CD) with a biologic compo...
(Date:10/6/2008)...- TARGIT Procedure May Eliminate 6 Weeks of Radiat...Treatment over the Internet Wednesday, October ...ra.com/explorehealth , HAMPTON, Va., Oct. 6 /PRNe... when she was diagnosed with breast cancer in May....east? How about radiation or chemotherapy?, , To...
(Date:10/6/2008)...cent study revealed that drinking polyphenol-rich ...hanges in appetite, energy intake or body,weight, ...nsumption of 100%,polyphenol-rich Concord grape ju... associated with changes in appetite and was shown...ta presented at the 49th Annual Meeting of,the Ame...
Breaking Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Concord Grape Juice Has No Significant Impact on Body Weight 2Concord Grape Juice Has No Significant Impact on Body Weight 3CellCyte Genetics Corp Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases 3175 1CellCyte Genetics Corp Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases 3175 2CellCyte Genetics Corp Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases 3175 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 1American Chemical Societys Weekly PressPac Feb 6 2008 11486 2American Chemical Societys Weekly PressPac Feb 6 2008 11486 3American Chemical Societys Weekly PressPac Feb 6 2008 11486 4American Chemical Societys Weekly PressPac Feb 6 2008 11486 5American Chemical Societys Weekly PressPac Feb 6 2008 11486 6American Chemical Societys Weekly PressPac Feb 6 2008 11486 7American Chemical Societys Weekly PressPac Feb 6 2008 11486 8American Chemical Societys Weekly PressPac Feb 6 2008 11486 9HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman 26 Friedman for 24575 Million 11481 1HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman 26 Friedman for 24575 Million 11481 2HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman 26 Friedman for 24575 Million 11481 3Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 1Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 2Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 3Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3167 4
..., 2007--The costs of eradicating,poliomyelitis fro...the short term, are much lower than the long term ...ication. And a recently developed,monovalent vacci...pe 1 poliomyelitis than an existing trivalent vacc...hed Online and in an upcoming,issue of The Lancet....
..., April 11, 2007 /PRNewswire-FirstCall/ --,Advance...two,additional Phase III clinical trials of ferumo...apeutic that are being,presented today at approxim...y Foundation,s Spring Clinical Meeting in Orlando,...tor section on the,company,s web site at <a target...
Other Medicine Technology:Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 2Costs of Eradicating Poliomyelitis Now Are Much Lower Than Trying,to Control It Later 3Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 2Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 3Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 4Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 5Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 6Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 7Advanced Magnetics Announces Positive Results from Two Additional,Phase III Studies of Ferumoxytol as an Intravenous Iron Replacement,Therapeutic 8
MVR Blades for water tight self sealing incision.
Lens Plus Daily Cleaner is the preservative-free daily cleaner for soft contact lenses.
For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p
Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro
Medicine Products: